|
1
|
Labeur TA, Berhane S, Johnson PJ. Response to: Prognostication of HCC patients under sorafenib is not always possible. Liver Int 2020; 40:1243-1244. [PMID: 31898390 DOI: 10.1111/liv.14335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Affiliation(s)
- Tim A Labeur
- Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands
| | - Sarah Berhane
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Philip J Johnson
- Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
| |
Collapse
|